What the FDA labels say about taking them together
Succinylcholine and thalidomide
Thalidomide's FDA label of March 24, 2023 names succinylcholine in its drug interactions section; the succinylcholine labels PlainMeds reads (2) do not name thalidomide.
Check it at the source: the succinylcholine FDA label on DailyMed (effective August 18, 2026, Hospira, Inc.); the thalidomide FDA label on DailyMed (effective March 24, 2023, Celgene Corporation).
What does the succinylcholine label say about thalidomide?
Succinylcholine's label (effective August 18, 2026) and its 1 other brand-application label do not name thalidomide in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (QUELICIN), Hospira, Inc., effective August 18, 2026 (SPL set fb08161e-7711-406d-e7b3-ea4515c07983), via openFDA; the full label on DailyMed
What does the thalidomide label say about succinylcholine?
Thalidomide label, drug interactionsNon-cardiac drugs that may cause bradycardia include H2 blockers (e.g., famotidine, cimetidine), lithium, tricyclic antidepressants and neuromuscular blockers (succinylcholine).
Source: FDA drug label (Thalomid), NDA020785 (Bristol-Myers), as published by Celgene Corporation, effective March 24, 2023 (SPL set 2eda833b-1357-4ed4-a093-194524fcb061), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Succinylcholine | Thalidomide | |
|---|---|---|
| Labeled for | n/a | Leukemia, lymphoma and myeloma |
| Boxed warning | Yes | Yes |
| Pharmacy cost (NADAC) | n/a | n/a |
| Shortage now | A presentation being discontinued | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once